Nifedipine Extended-Release Tablets — Class III drug recall D-0630-2017
Terminated recall by Alvogen, Inc, reported 2017-04-12, distributed nationwide. Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
| Recall number | D-0630-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Alvogen, Inc, Pine Brook, NJ, United States |
| Recall initiated | 2017-03-07 |
| Classified | 2017-04-04 |
| Reported by FDA | 2017-04-12 |
| Terminated | 2017-12-15 |
| Distributed | Nationwide (US) |
| NDC | 47781-0369-01 |
| Lot numbers | BXH1BE1A, BXH1BE1B, BXH1BE2, BXH1BEE1, BXH1P41, BXH1P41A, BXH5ZR1, BXH81R1, BXH9AL1A, BXHBD41A, BXHCUD1A, BXHCUF2A |
| Expiration dates | 2018-01, 2018-06, 2019-01 |
Product
Nifedipine Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 07058 USA, NDC 47781-369-01.
Reason for recall
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0630-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.